Tocopherol (vitamin E) in Alzheimer's disease and other neurodegenerative disorders

被引:53
作者
Berman, K
Brodaty, H [1 ]
机构
[1] Prince Wales Hosp, Euroa Ctr, Acad Dept Old Age Psychiat, Randwick, NSW 2031, Australia
[2] Univ New S Wales, Sch Psychiat, Sydney, NSW, Australia
关键词
D O I
10.2165/00023210-200418120-00005
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
In this article, we review the evidence that tocopherol (vitamin E) may have a role to play in the prevention and treatment of Alzheimer's disease and other neurological diseases. The theoretical rationale for the effectiveness of tocopherol as treatment and/or prevention of Alzheimer's disease is based on its antioxidant properties. Results from animal and in vitro studies provide evidence to support use of tocopherol for prevention and treatment of degenerative neurological diseases. Furthermore, several, but not all, epidemiological, cross-sectional, prospective studies indicate that tocopherol may have protective effects in Alzheimer's disease, although dietary and supplemental forms of the vitamin may differ in their efficacy. Mixed results have been obtained from clinical trials. Evidence of the use of tocopherol as a protective measure or as therapy in neurological diseases other than Alzheimer's disease is less compelling. To date, there are no clear-cut answers as to whether tocopherol is worth prescribing, but current clinical practice favours its use in the treatment of Alzheimer's disease.
引用
收藏
页码:807 / 825
页数:19
相关论文
共 131 条
[1]  
Adamian GG, 2001, ACTA PHYS HUNG NS-H, V14, P3, DOI 10.1556/APH.14.2001.1-4.2
[2]   Long-term treatment effects of vitamin E for tardive dyskinesia [J].
Adler, LA ;
Edson, R ;
Lavori, P ;
Peselow, E ;
Duncan, E ;
Rosenthal, M ;
Rotrosen, J .
BIOLOGICAL PSYCHIATRY, 1998, 43 (12) :868-872
[3]   Vitamin E treatment for tardive dyskinesia [J].
Adler, LA ;
Rotrosen, J ;
Edson, R ;
Lavori, P ;
Lohr, J ;
Hitzemann, R ;
Raisch, D ;
Caligiuri, M ;
Tracy, K .
ARCHIVES OF GENERAL PSYCHIATRY, 1999, 56 (09) :836-841
[4]   IRFI 042, a novel dual vitamin E-like antioxidant, inhibits activation of nuclear factor-κB and reduces the inflammatory response in myocardial ischaemia-reperfusion injury [J].
Altavilla, D ;
Deodato, B ;
Campo, GM ;
Arlotta, M ;
Miano, M ;
Squadrito, G ;
Saitta, A ;
Cucinotta, D ;
Ceccarelli, S ;
Ferlito, M ;
Tringali, M ;
Minutoli, L ;
Caputi, AP ;
Squadrito, F .
CARDIOVASCULAR RESEARCH, 2000, 47 (03) :515-528
[5]  
*ALZH RES FOR, ALPH TOC VIT E
[6]   DOUBLE-BLIND TRIAL OF VITAMIN-E IN ANGINA-PECTORIS [J].
ANDERSON, TW ;
REID, DBW .
AMERICAN JOURNAL OF CLINICAL NUTRITION, 1974, 27 (10) :1174-1178
[7]  
Apostolski Slobodan, 1998, Journal of Environmental Pathology Toxicology and Oncology, V17, P325
[8]   Protective effects of grape seed proanthocyanidins and selected antioxidants against TPA-induced hepatic and brain lipid peroxidation and DNA fragmentation, and peritoneal macrophage activation in mice [J].
Bagchi, D ;
Garg, A ;
Krohn, RL ;
Bagchi, M ;
Bagchi, DJ ;
Balmoori, J ;
Stohs, SJ .
GENERAL PHARMACOLOGY, 1998, 30 (05) :771-776
[9]  
Barak Y, 1998, Ann Clin Psychiatry, V10, P101, DOI 10.3109/10401239809148942
[10]   Vitamin E protects neurons against oxidative cell death in vitro more effectively than 17-β estradiol and induces the activity of the transcription factor NF-κB [J].
Behl, C .
JOURNAL OF NEURAL TRANSMISSION, 2000, 107 (04) :393-407